RAYMOND DEBBANE
CIK 1053890 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$595.52M
Companies
7
Total Filings
124
Lifetime Open-Market Net
-$72.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | Director | 3,533,960 | $2.40 | $8.48M | $5.43M | 35 | 2026-06-04 |
| SRRK | 10%+ Owner | 11,051,166 | $51.89 | $573.45M | -$78.79M | 1 | 2024-11-27 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 71,464 | $15.70 | $1.12M | -$355.5K | 1 | 2024-08-05 |
| WW | Director | 134,387 | $15.87 | $2.13M | $320.1K | 18 | 2023-05-11 |
| WTW | Director | 33,426 | $343.01 | $11.47M | $1.00M | 62 | 2019-04-03 |
| BUFF | Director | 0 | $53.63 | $0 | $0 | 3 | 2018-04-24 |
| Ceres, Inc. (CERE) Delisted | Director | — | $44.96 | — | $0 | 3 | 2014-03-11 |
Recent Filings · Page 7 of 13
124 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-07-07 | WTW | Grant (A) | +820 | $0 | EDGAR |
| 2016-05-02 | LXRX | Grant (A) | +1,432 | $0 | EDGAR |
| 2016-04-06 | WTW | Grant (A) | +656 | $0 | EDGAR |
| 2016-04-05 | BUFF | Grant (A) | +3,324 | $0 | EDGAR |
| 2016-03-03 | WTW | Buy (P) | +83,125 | $1.00M | EDGAR |
| 2016-01-06 | WTW | Grant (A) | +462 | $0 | EDGAR |
| 2015-12-17 | WTW | Grant (A) | +1,000 | $0 | EDGAR |
| 2015-10-07 | WTW | Grant (A) | +1,514 | $0 | EDGAR |
| 2015-07-08 | WTW | Grant (A) | +1,977 | $0 | EDGAR |
| 2015-04-24 | LXRX | Grant (A) | +18,691 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.